Glucosylceramides (GlcCer) are biosynthetic precursors of glycosphingolipid
s. They are widely distributed in biological systems where they exhibit num
erous biological functions. Studies on the localization of glucosylceramide
s in different tissues have used biochemical methods only since specific an
tibodies against GlcCer were not previously available. We have characterize
d two commercially available rabbit antisera which were prepared against Gl
cCer of plant origin (1-O-(beta-D-glucopyranosyl)-N-acyl-4-hydroxysphingani
ne; GlcCer-3) or human origin (1-O-(beta-D-glucopyranosyl)-N-acyl-sphingosi
ne; GlcCer-2) and claimed to be specific for GlcCer, The antisera were also
able to detect specifically GlcCer species in crude lipid extracts from hu
man epidermis after separation by thin-layer chromatography, The reagents a
re sensitive since both antisera reacted at dilutions higher than 1:500 wit
h their homologous antigen in the nanogram range in thin layer immunostaini
ng or dot-blot assays. The antisera are specific for GlcCer although they d
id not differentiate between GlcCer-2 and GlcCer-3 containing sphingosine o
r 4-hydroxysphinganine. The antisera also reacted with N-stearoyl-DL-dihydr
oglucocerebroside indicating that the naturally occurring structural variat
ions in the amino alcohol moiety are not determining the specificity. No cr
ossreactivity was observed with other mono- or diglycosylceramides (galacto
sylceramides, lactosylceramide), free ceramides or structurally unrelated l
ipids (cholesterol, sphingomyelin, or phospholipids). Therefore, the glycos
ylmoiety seems to represent the major antigenic determinant. Finally, the a
ntisera also proved to be useful for the immunohistochemical localization o
f GlcCer in human epidermis by which earlier biochemical data on the distri
bution of GlcCer in the various epidermal layers were confirmed.